Recently published findings suggest that WBV
increases trabecular and cortical bone mass in db / db mice (44), but these effects differ from the modest skeletal responses observed after exercise and WBV in the current study.
Not exact matches
The small
increase in the high - dose group did not translate into beneficial effects because authors found no difference between the three study groups for changes in spine, average total - hip, average femoral neck or total - body bone mineral density,
trabecular bone score, muscle mass or sit - to - stand tests.
The effect of glucocorticoid treatment is most prominent on
trabecular bone and is therefore likely to be larger on vertebral bone than on hip bone.3 Glucocorticoids are associated with an
increased rate of fracture, and higher doses and longer use of glucocorticoids are associated with higher risks of fracture.4 Compared with patients not taking glucocorticoids, the risk of hip and vertebral fracture among patients taking glucocorticoids is
increased by 60 % and 160 %, respectively.4 Among 80 - year - old patients, the hip fracture risk is
increased by a magnitude of 2.1 and is independent of BMD.5 Most studies indicate that fracture risk is
increased following at least 3 months of treatment with daily doses of 5 mg of prednisolone or more in older men and women.4
There was also
increased fluorescence in the area of the
trabecular meshwork and posterior limbus of greater magnitude than in the unwounded condition (Figure 7B).
Summary: Patients with primary open - angle glaucoma (POAG) often present with chronically elevated intraocular pressure (IOP), the result of
increased resistance to aqueous humor outflow through the
trabecular meshwork.
TGF - Î ² 2 is known to elevate IOP by promoting
increases in aqueous humor outflow resistance through the
trabecular meshwork.
Some (8 per cent) of the treated women even experienced a significant
increase in
trabecular bone density.